당뇨병 환자에서 우울 및 불안증상과 자아탄력성, 사회적 갈등 및 지지 사이의 연관

• Published in: 대한불안의학회지, 16(1) pp. 9 - 17
• Main Authors: 정회운, 김상훈, 박상학, 김승곤, 김정호, 서은현, 윤형준
• Format: Journal Article
• Language: Korean
• Published: 대한불안의학회 01.04.2020
• Subjects: 정신과학
• ISSN: 2586-0151; 2586-0046
• DOI: 10.24986/anxmod.2020.16.1.002

Objective : The purpose of this study was to investigate the association of depressive/anxiety symptoms with psychosocial factors including ego resilience, social conflict, and social support as well as hemoglobin A1c in patients with diabetes mellitus (DM). Methods : The subjects were 144 patients with DM. Depressive/anxiety symptoms were evaluated by the Hospital Anxiety and Depression Scale. Sociodemographic factors, hemoglobin A1c, ego resilience, social conflict, and social support were measured. Multiple regression analyses were performed to examine the impact of hemoglobin A1c, ego resilience, social conflict, and social support on depressive/anxiety symptoms. Results : A total of 32.6% and 24.3% of participants were identified with depressive and anxiety symptoms, respectively. Depressive/anxiety symptoms positively correlated with the social conflict score. Conversely, ego resilience and social support negatively correlated with depressive/anxiety symptoms. In the final model of the multiple regression analyses, ego resilience was associated with a lower level of depressive (β=-0.083, p=0.019)/anxiety (β=-0.125, p=0.001) symptoms whereas social conflict was related to a higher level of depressive (β=0.353, p=0.011)/anxiety (β=0.460, p=0.003) symptoms. Also, hemoglobin A1c positively associated with anxiety symptoms (β=0.495, p=0.012) whereas social support negatively related to depressive symptoms (β=-0.464, p=0.004). Conclusion : We found possible risk and protective psychosocial factors of underlying depressive/anxiety symptoms among patients with DM. Our findings suggest that enhancing ego resilience and social support as well as decreasing social conflict would be crucial in the prevention and management of depressive/ anxiety symptoms in patients with DM. (Anxiety and Mood 2020;16(1):9-17) KCI Citation Count: 0